(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -33.23%11.74B | -44.47%5.6B | -16.51%30.75B | -10.43%23.23B | 19.51%17.59B | 50.29%10.09B | 63.53%36.83B | 99.09%25.93B | 88.83%14.72B | 129.78%6.71B |
Operating income | -33.23%11.74B | -16.51%30.75B | 19.51%17.59B | 63.53%36.83B | 88.83%14.72B | |||||
Operating expenses | -10.23%-10.45B | 14.32%-4.29B | -24.29%-20.47B | -18.76%-14.04B | -51.02%-9.48B | -58.77%-5.01B | -24.45%-16.47B | -11.82B | -18.17%-6.28B | -3.15B |
Gross profit | -84.05%1.29B | -49.49%10.29B | -3.93%8.11B | 119.18%20.37B | 240.11%8.44B | |||||
Selling expenses | -18.30%-282.98M | ---- | -11.93%-736.12M | ---- | 16.55%-239.21M | ---- | 11.42%-657.66M | ---- | -65.14%-286.67M | ---- |
Administrative expenses | -22.21%-452.04M | ---- | -8.96%-987.72M | ---- | -16.55%-369.9M | ---- | -29.05%-906.49M | ---- | -55.97%-317.37M | ---- |
Research and development expenses | -93.35%-181.17M | ---- | 15.77%-274.03M | ---- | 25.22%-93.7M | ---- | 3.53%-325.35M | ---- | -124.90%-125.3M | ---- |
Profit from asset sales | 84.63%-516.32K | ---- | 8.99%-38.68M | ---- | -287.74%-3.36M | ---- | -3,009.56%-42.5M | ---- | 636.59%1.79M | ---- |
Revaluation surplus | 102.19%638.26K | ---- | -396.34%-30.11M | ---- | -98.11%-29.13M | ---- | -6,993.23%-6.07M | ---- | -117.40%-14.7M | ---- |
-Changes in the fair value of other assets | 102.19%638.26K | ---- | -396.34%-30.11M | ---- | -98.11%-29.13M | ---- | -6,993.23%-6.07M | ---- | -117.40%-14.7M | ---- |
Impairment and provision | -53.71%-1.03B | ---- | -154.38%-1.6B | ---- | -389.93%-672.1M | ---- | 9.04%-629.87M | ---- | -125.97%-137.18M | ---- |
-Other impairment is provision | -53.71%-1.03B | ---- | -154.38%-1.6B | ---- | -389.93%-672.1M | ---- | 9.04%-629.87M | ---- | -125.97%-137.18M | ---- |
Special items of operating profit | -63.52%67.9M | ---- | 115.72%301.09M | ---- | 132.49%186.12M | ---- | -62.15%139.58M | ---- | 70.14%80.05M | ---- |
Operating profit | -109.97%-673.2M | -61.95%6.68B | -9.39%6.76B | 150.14%17.55B | 278.80%7.46B | |||||
Financing cost | 12.45%-280.44M | ---- | 13.29%-608.8M | ---- | 8.10%-320.33M | ---- | 1.64%-702.14M | ---- | -18.38%-348.58M | ---- |
Special items of earning before tax | 74.41%12.43M | ---- | 205.65%35.21M | ---- | 152.11%7.12M | ---- | -309.51%-33.32M | ---- | -154.77%-13.67M | ---- |
Earning before tax | -114.61%-941.21M | -63.70%6.1B | -9.18%6.44B | 166.13%16.82B | 317.57%7.09B | |||||
Tax | 108.93%93.4M | ---- | 60.44%-987.15M | ---- | 1.60%-1.05B | ---- | -167.06%-2.5B | ---- | -209.00%-1.06B | ---- |
After-tax profit from continuing operations | -115.71%-847.82M | -64.26%5.12B | -10.51%5.4B | 165.97%14.32B | 345.14%6.03B | |||||
Earning after tax | -115.71%-847.82M | -64.26%5.12B | -10.51%5.4B | 165.97%14.32B | 345.14%6.03B | |||||
Minority profit | -93.85%39.2M | ---- | -23.13%772.49M | ---- | 54.35%637.39M | ---- | 134.40%1B | ---- | 226.38%412.95M | ---- |
Profit attributable to shareholders | -118.64%-887.02M | -89.64%359.13M | -67.37%4.35B | -47.37%5.08B | -15.28%4.76B | 39.16%3.47B | 168.70%13.31B | 201.45%9.65B | 357.37%5.62B | 931.32%2.49B |
Basic earnings per share | -118.64%-0.6203 | -67.37%3.0385 | -15.28%3.328 | 137.27%9.3111 | 283.80%3.9282 | |||||
Diluted earnings per share | -118.64%-0.6203 | -67.37%3.0385 | -15.28%3.328 | 137.27%9.3111 | 283.80%3.9282 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data